(Q40433554)

20 September 2017

1 reference

title

Medical disorders in the schizophrenic patient (English)

1 reference

20 September 2017

Medical Disorders in the Schizophrenic Patient (English)

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

main subject

schizophrenia

0 references

schizophrenic psychology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591491

31 May 2024

patient care team

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591491

31 May 2024

author name string

V. Vieweg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591491

31 May 2024

J. Levenson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591491

31 May 2024

A. Pandurangi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591491

31 May 2024

J. Silverman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7591491

31 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7591491

31 May 2024

publication date

1 January 1995

1 reference

full work available at URL

20 September 2017

http://journals.sagepub.com/doi/pdf/10.2190/TTYA-A89T-2YT9-UK2A

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

International Journal of Psychiatry in Medicine

31 May 2024

published in

1 reference

20 September 2017

volume

25

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

137-172

1 reference

Effect of antipsychotic medication on speed of information processing in schizophrenic patients

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Phenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Erratic eye tracking in schizophrenic patients as revealed by high-resolution techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

A possible role of hippocampal dysfunction in schizophrenic symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

CT abnormalities in schizophrenia. A preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

P300 in schizophrenia: interactions between amplitudes and topography

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Molecular pathology of schizophrenia: more than one disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Positive and negative symptoms in schizophrenia. A critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Family management in the prevention of exacerbations of schizophrenia: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The economic costs of schizophrenia. Implications for public policy

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Mortality in psychiatric hospitals in Norway 1950?74

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The Mortality Experience of a Population with Psychiatric Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Excess mortality among psychiatric patients. The Iowa Record-Linkage Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Mentally ill chemical abusers discharged from VA inpatient treatment: 1976-1988.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Substance Abuse in an Inpatient Psychiatric Sample

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Prevalence of alcohol and drug abuse in schizophrenic inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Past substance abuse and clinical course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Psychiatric disorder, drinking and alcoholism: what are the links?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Drug and alcohol abuse among psychiatric admissions. A multidrug clinical-tosicologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Unrecognized cocaine use among schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

LSD psychosis or LSD-induced schizophrenia? A multimethod inquiry

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Characteristics of Drug Abusers Admitted to a Psychiatric Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Marijuana use in schizophrenia: a clear hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Observation on two psychotomimetic drugs of piperidine derivation--CI 395 (sernyl) and CI 400

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Prevalence of smoking among psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Effects of smoking on fluphenazine clearance in psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Physical Comorbidity in Elderly Veterans Affairs Patients With Schizophrenia and Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Cancer mortality among patients in New York mental hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Physical illness and psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Schizophrenia and intercurrent physical illness: A critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Biochemical aspects of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Schizophrenia and rheumatic disease. A study on the concurrence of inflammatory joint diseases and a review of 58 case-records

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The changing drug scene: 1970-1972.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Caffeine-induced delirium during prolonged competitive stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Anxiety and depression associated with caffeinism among psychiatric inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Increased anxiogenic effects of caffeine in panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Effects of caffeine on behavior of schizophrenic inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

psychiatric symptoms in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF PERIARTERITIS NODOSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Psychiatric disorders in primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Neuropsychiatric effects of anabolic steroids in male normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

MENTAL ILLNESSES IN HYPOTHYROID PATIENTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

An investigation into some psychiatric aspects of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Differential diagnosis and management of the patient with megaloblastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Cerebral manifestations of vitamin-B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

HIV infection presenting as psychosis: a critique

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Chronic schizophrenia: a risk factor for HIV?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The schizophrenialike psychoses of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Schizophrenia, epilepsy, cancer, methionine, and folate metabolism. Pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Schizophrenia in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Treatment of the psychotic pregnant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The offspring of schizophrenics. Fetal and neonatal deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Possible teratogenic effect of phenothiazines in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

The rational use of psychotropic drugs in pregnancy and postpartum

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Effect of Prenatal Drugs on the Behavior of the Neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Concurrent medical illness in the schizophrenic patient. Epidemiology, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Mother and baby unit: psychiatric survey of 115 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Psychiatric admission of mentally ill mothers with their infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Physical Illness Presenting as Psychiatric Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Diagnosis and treatment of physical disease in the mentally ill

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Is there a stethoscope in the house (and is it used)?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Physical illness manifesting as psychiatric disease. II. Analysis of a state hospital inpatient population

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Medical evaluation of psychiatric patients. I. Results in a state mental health system

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Reactions of schizophrenics to life-threatening disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Risperidone in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Torsade de pointes associated with the use of intravenous haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome) and concurrent psychotropic drug administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Current concepts. The malignant hyperthermia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Treatment of the Neuroleptic Malignant Syndrome With Bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Neuroleptic malignant syndrome. Successful treatment with bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Geriatric psychopharmacology. A primary care challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FTTYA-A89T-2YT9-UK2A

Schizophrenia and physical disease

21 January 2018

18

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

20

44

42

Tsuang M. T.

1983

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Causes of death in DSM-III schizophrenics and other psychotics (atypical group). A comparison with the general population

31 May 2024

21

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Leading causes of death in institutionalized chronic schizophrenic patients: a study of 1,275 autopsy protocols

31 May 2024

23

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Prevalence estimates of substance abuse in schizophrenia and their correlates

31 May 2024

26

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Alcohol abuse in the psychiatric hospital population

31 May 2024

27

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Alcohol use and abuse in schizophrenia. A prospective community study

31 May 2024

30

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Is risk for substance abuse unitary?

31 May 2024

36

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment

31 May 2024

38

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Effects of cocaine on hospital course in schizophrenia.

31 May 2024

39

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

LSD and onset of schizophrenia

31 May 2024

47

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history

31 May 2024

51

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Morphine as an Antipsychotic?

31 May 2024

54

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

55

45

9

O'Brien C. P.

1984

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Smoking and malignancy in schizophrenia

31 May 2024

59

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Linked record medical information systems

31 May 2024

64

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Causes of death in schizophrenia and manic-depression

31 May 2024

69

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Common medical disorders rarely found in psychotic patients

31 May 2024

71

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Absence of Rheumatoid Arthritis in Schizophrenia*

31 May 2024

75

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

82

39

732

Mikkelsen E.

1978

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Canadian Medical Association Journal

31 May 2024

87

91

1366

Agras S.

1964

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Acute adverse reactions to prednisone in relation to dosage

31 May 2024

92

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Presentation of the Steroid Psychoses

31 May 2024

93

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Western Journal of Medicine

31 May 2024

109

146

615

Cummings M. A.

1987

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

The coincidence of schizophrenia and Parkinsonism: some neurochemical implications

31 May 2024

112

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Factors influencing the occurrence of schizophrenia-like psychosis in patients with temporal lobe epilepsy

31 May 2024

116

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Management of psychotic pregnant patients in a medical-psychiatric unit

31 May 2024

118

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy

31 May 2024

125

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Canadian Medical Association Journal

31 May 2024

126

88

375

Moriarty A. J.

1963

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

128

9

275

Miller L. J.

1991

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Maternal psychotropic medication and neonatal behavior

31 May 2024

129

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Extrapyramidal dysfunction in an infant of a schizophrenic mother

31 May 2024

130

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation.

31 May 2024

132

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Convulsive therapy in psychoses accompanying pregnancy

31 May 2024

133

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Case report of ECT during high-risk pregnancy

31 May 2024

134

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Infant jaundice after phenothiazine drugs for labor: an enigma

31 May 2024

140

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Admitting schizophrenic mothers with their babies

31 May 2024

146

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

147

225

1295

Sneddon J.

1981

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Medical illness in psychiatric patients: barriers to diagnosis and treatment

31 May 2024

151

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Communication Difficulty of Patients With Schizophrenia and Physical Illness

31 May 2024

160

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Neuroleptic malignant syndrome

31 May 2024

167

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

169

41

79

Caroff S. N.

1980

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

171

58

758

Gallant E. M.

1983

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine

31 May 2024

172

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

Psychopharmacology Bulletin

31 May 2024

175

27

381

Sakkas P.

1991

1 reference

https://api.crossref.org/works/10.2190/TTYA-A89T-2YT9-UK2A

31 May 2024

Identifiers

1 reference

20 September 2017

1 reference